68 related articles for article (PubMed ID: 3286444)
1. Mutant insulin syndromes.
Vinik A; Bell G
Horm Metab Res; 1988 Jan; 20(1):1-10. PubMed ID: 3286444
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.
Wang J; Takeuchi T; Tanaka S; Kubo SK; Kayo T; Lu D; Takata K; Koizumi A; Izumi T
J Clin Invest; 1999 Jan; 103(1):27-37. PubMed ID: 9884331
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
Flechtner I; de Lonlay P; Polak M
Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
[TBL] [Abstract][Full Text] [Related]
5. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
Hrnciar J
Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
[TBL] [Abstract][Full Text] [Related]
6. Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.
Sakura H; Iwamoto Y; Sakamoto Y; Kuzuya T; Hirata H
J Clin Invest; 1986 Dec; 78(6):1666-72. PubMed ID: 3537011
[TBL] [Abstract][Full Text] [Related]
7. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.
Nanjo K; Sanke T; Miyano M; Okai K; Sowa R; Kondo M; Nishimura S; Iwo K; Miyamura K; Given BD
J Clin Invest; 1986 Feb; 77(2):514-9. PubMed ID: 3511099
[TBL] [Abstract][Full Text] [Related]
8. [Abnormal insulinemia].
Nanjo K
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):890-5. PubMed ID: 3078053
[No Abstract] [Full Text] [Related]
9. Factitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy.
Giurgea I; Ulinski T; Touati G; Sempoux C; Mochel F; Brunelle F; Saudubray JM; Fekete C; de Lonlay P
Pediatrics; 2005 Jul; 116(1):e145-8. PubMed ID: 15995015
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
11. The renal metabolism of insulin: urinary insulin excretion in patients with mutant insulin syndrome (insulin Wakayama).
Hanabusa T; Oki C; Nakano Y; Okai K; Nishi M; Sasaki H; Sanke T; Nanjo K
Metabolism; 2001 Aug; 50(8):863-7. PubMed ID: 11474471
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) gene.
Huang Z; Li Y; Tang T; Xu W; Liao Z; Yao B; Hu G; Weng J
Clin Endocrinol (Oxf); 2009 Nov; 71(5):659-65. PubMed ID: 19170714
[TBL] [Abstract][Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. [Hypoglycemia and transient diabetes mellitus in an insulin autoimmune syndrome].
Reisch N; Zwermann O; Reincke M
Dtsch Med Wochenschr; 2004 May; 129(20):1135-8. PubMed ID: 15143456
[TBL] [Abstract][Full Text] [Related]
15. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
Hansen L
Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
[TBL] [Abstract][Full Text] [Related]
16. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations.
Kapoor RR; Locke J; Colclough K; Wales J; Conn JJ; Hattersley AT; Ellard S; Hussain K
Diabetes; 2008 Jun; 57(6):1659-63. PubMed ID: 18268044
[TBL] [Abstract][Full Text] [Related]
17. Genetics of type 2 diabetes mellitus.
Malecki MT
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S10-21. PubMed ID: 15955369
[TBL] [Abstract][Full Text] [Related]
18. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.
Hegele RA
Mol Genet Metab; 2000 Dec; 71(4):539-44. PubMed ID: 11136544
[TBL] [Abstract][Full Text] [Related]
19. Lessons learned from molecular biology of insulin-gene mutations.
Steiner DF; Tager HS; Chan SJ; Nanjo K; Sanke T; Rubenstein AH
Diabetes Care; 1990 Jun; 13(6):600-9. PubMed ID: 2192846
[TBL] [Abstract][Full Text] [Related]
20. A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).
Yano H; Kitano N; Morimoto M; Polonsky KS; Imura H; Seino Y
J Clin Invest; 1992 Jun; 89(6):1902-7. PubMed ID: 1601997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
